Antifungal activity of cinnamon oil and olive oil against Candida spp. Isolated from blood stream infections

Journal of Clinical and Diagnostic Research

Volumn 10, Issue 8, 2016, Pages DC09-DC11

  Goel, Nidhi ^a   Rohilla, Hina ^a   Sing, Gajender ^a   Punia, Parul ^a  

^a POST GRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Antifungal susceptibility; Candidemia; Essential oil; Fluconazole

Indexed keywords

CINNAMON EXTRACT; CINNAMON OIL; FLUCONAZOLE; OLIVE OIL; UNCLASSIFIED DRUG; VORICONAZOLE;

ADOLESCENT; ADULT; ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BLOODSTREAM INFECTION; CANDIDA; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDEMIA; CHILD; FEMALE; HUMAN; INFANT; INHIBITION ZONE; LOW BIRTH WEIGHT; MALE; MINIMUM INHIBITORY CONCENTRATION; NEWBORN; NONHUMAN; OBSERVATIONAL STUDY; PREMATURITY; PREVALENCE; PROSPECTIVE STUDY;

EID: 84986184261     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2016/19958.8339     Document Type: Article

References (26)

1. Oberoi JK, Wattal C, Goel N, Raveendran R, Datta S, Prasad K. Non-albicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India. Indian J Med Res. 2012;136:997-1003.
2. Sanglard D. Emerging Threats in Antifungal-Resistant Fungal Pathogens. Frontiers in Medicine. 2016;3:11-13.
3. Upadhyay RK, Dwivedi P, Ahmad S. Screening of antibacterial activity of six plant essential oils against pathogenic bacterial strains. Asian J Med Sci. 2010;2:152-58.
4. Rathi SG, Bhaskar VH, Patel PG. Invitro Anti fungal Screening of Embelia ribes Plant Extract through EUCAST Method. Int J PharmaSci and Research. 2010;1:134-38.
5. thed. New York: Churchill Livingstone; 1996. Pp. 714-17.
6. Chander J. Fungal culture media. In: Chander J, editor. Textbook of Medical Mycology. 3rd edition. New Delhi: Mehta Publishers; 2009. Pp. 508-13.
7. Reference method for broth dilution testing of yeast approved standard. 2nd ed. Wayne, PA: NCCLS; 2002. National Committee for Clinical Laboratory Standards. M.27-A2.
8. Fiori ACG, Schwan-Estrada KRF, Stangarlin JR, Vida JB, Scapim CA, Guz MES, Pascholti SF. Antifungal Activity of Leaf Extracts and Essential Oils of some Medicianal Plants against Didymellabryonial. J. Phytopathol. 2000;148:483.
9. Junior A, Zanil C. Biological Screening of Brazilian medicinal plants. Bra J Sci. 2000;95:367-73.
10. Giri S, Kindo AJ. A review of Candida species causing blood stream infections. Indian J Med Microbiol. 2012;30:270-78.
11. Xess I, Jain N, Hasan F, Mandal P, Banerjee U. Epidemiology of Candidemia in a tertiary care centre of North India: 5 year study. Infect. 2007;35:256-59.
12. Tritipwanit K, Chindamporn A, Suankratay C. Epidemiology of Candidemia at King Chulalongkorn Memorial Hospital, Thailand. J Infect Dis Antimicrobial Agents. 2005;22:59-69.
13. Jose A, Rodrigue N, Kusne S, Manez R, Irish W, Linden P, et al. Factors associated with the development of Candidemia and Candidemia related death among liver transplant recipients. Annals of Surgery. 1996;223:70-76.
14. Osaba AO, Al-Mowallad AW, McAlear DE, Hussein BA. Candidemia and the susceptibility pattern of Candida isolates in blood. Saudi Med J. 2003;24:1060-63.
15. Marchetti O, Bille J, Fluckiger U, Eggimann P, Ruef C, Garbino J, et al. Epidemiology of Candidemia in Swiss tertiary care hospitals: Secular trends 1991-2000. Clin Infect Dis. 2004;38:311-20.
16. Deorukhkar SC, Santosh S. species distribution and antifungal susceptibility profile of Candida species isolated from bloodstream infections. J Evolution Med and Dental Sci. 2012;1:241-43.
17. Amrutkar PP, Rege MD, Chen H, Gentry LO, Garey KW. Comparison of risk factors for Candidemia versus bacteraemia in hospitalized patients. Infection. 2006;34:322-27.
18. Shivaprakasha S, Radhakrishnan K, Karim PMS. Candida spp. other than Candida albicans: A major cause of fungemia in a tertiary care centre. IJMM. 2007;4:405-07.
19. Baradkar VP, Mathur M, Kumar S, Rathi M. Candida glabrata: Emerging pathogen in neonatal sepsis, Ann Tropical Med Public Health. 2008;1:5-8.
20. Goel N, Ranjan KP, Aggarwal R, Chaudhary U, Nanda S. Emergence of Non-albicans Candida in neonatal septicaemia and antifungal susceptibility: Experience from a tertiary care centre. J Laboratory Physician. 2009;2:1-10.
21. Mokaddas EM, Al-Sweih NA, Khan ZU. Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait: a 10-year. Study. J Med Microbiol. 2007;56:255-59.
22. Bagg J, Sweeney MP, Davies AN, Jackson MS, Brailsford S. Voriconazole susceptibility of yeasts isolated from the mouths of patients with advanced cancer. J Med Microbiol. 2005;54:959-64.
23. Magill SS, Shields C, Sears CL, Choti M, Merz WG. Triazole cross resistance among Candida spp: case report, occurrence among bloodstream isolates and implications for antifungal therapy. J Clin Microbiol. 2006;44:529-35.
24. Panackal AA, Gribskov JL, Staab JF, Kirby KA, Rinaldi M, Marr KA. Clinical Significance of Azole Antifungal Drug Cross-Resistance in Candida glabrata. J Clin Microbiol. 2006;44:1740-43.
25. Pattnaik S, Pradhan DK, Jana GK. Evaluation of cinnamon oil, peppermint oil, cardamom oil and orange oil as antimicrobial agents. J Pharm Res. 2010;2:414-16.
26. Devkatte AN, Zore GB, Karuppayil SM. Potential of plant oils as inhibitor of Candida albicans growth. FEMS yeast research. 2005;5(9):867-73.